AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet AMPE Quote Ampio Pharm

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 27 5 8
ShortTermInvest 0 0 0
Cash 27 5 8
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 29 5 8
PPE 11 10 10
AccumulatedDepr -1 -2 -4
NetPPE 9 8 7
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 11 0 0
OtherLTAssets 1 0 0
TotalNonCurrent 21 8 7
TotalAssets 50 14 15
ShortTermDebt 0 0 0
AccountsPayable 3 0 0
TaxesPayable 0 0 0
AccruedLiabilit 0 0 0
DeferredRevenue 0 0 0
OtherCurrentLia 3 2 4
TotalCurrentLia 6 2 4
Debt 5 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 2 5 46
TotalNonCurrent 8 5 46
TotalLiabilitie 13 7 49
CommonStock 0 0 0
AdditionalPaidI 171 160 171
RetainedEarning -134 -153 -205
AccumulatedOthe 0 0 0
TotalStockholde 37 7 -34
TotalLiabilitie 50 14 15
Ampio Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Ampio Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.